ARNA

Q: What is the price of Arena Pharmaceuticals (ARNA) today?

The current price of Arena Pharmaceuticals (ARNA) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Arena Pharmaceuticals (ARNA) pay dividends?

Arena Pharmaceuticals (ARNA) did not pay dividends over the past year.

Arena Pharmaceuticals Inc.

Price

$ -

return (12m)

0.00%

p/e

-9.92

p/bv

9.08

DIVIDEND YIELD

0.00%

ARNA price

Arena Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ARNA

review the fundamentals of Arena Pharmaceuticals shares

P/E

-9.92

Sector: -3.88 Industry: -3.88

P/S (PSR)

-1,731.35

Sector: -4.22 Industry: -4.22

P/BV

9.08

Sector: 1.96 Industry: 1.96

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-78.56%

Sector: -64.79% Industry: -64.79%

ROE

-91.56%

Sector: -65.33% Industry: -65.33%

ROIC

Sector: -2,907.20% Industry: -2,907.20%

NET MARGIN

100.00%

Sector: -39.82% Industry: -39.82%

GROSS MARGIN

-1.53%

Sector: 36.79% Industry: 36.79%

OPERATING MARGIN

100.00%

Sector: -38.80% Industry: -38.80%

EV/EBITDA

-12.98

Sector: -3.99 Industry: -3.99

EV/EBIT

-12.85

Sector: -4.06 Industry: -4.06

PRICE-TO-ASSETS

7.79

Sector: 1.44 Industry: 1.44

BVPS

11.01

Sector: 1.91 Industry: 1.91

EPS

-10.08

Sector: -2.12 Industry: -2.12

EQUITY-TO-ASSETS RATIO

0.86

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

0.86

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals ARNA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.67	6.91	25.92%	2.23%	$ 561.22 B	21.83%
PFE	19.36	1.60	8.29%	6.75%	$ 145.01 B	11.83%
ABBV	105.03	-57.74	-54.98%	3.12%	$ 381.79 B	5.79%
NVO	10.53	6.36	60.40%	4.15%	$ 199.76 B	37.15%
MRK	33.87	6.59	19.45%	2.71%	$ 302.60 B	13.59%
AZN	27.89	6.11	21.93%	1.71%	$ 289.71 B	17.19%
GILD	18.11	7.12	39.33%	2.37%	$ 166.88 B	30.99%
BMY	16.66	6.03	36.19%	4.20%	$ 121.18 B	15.01%
ZTS	12.98	10.61	81.75%	2.50%	$ 34.32 B	27.79%
REGN	15.02	2.11	14.08%	0.56%	$ 66.44 B	29.65%
HALO	23.11	36.70	158.82%	0.00%	$ 8.06 B	23.13%
AMGN	23.49	19.94	84.87%	2.85%	$ 183.22 B	20.96%
MCK	19.63	-112.06	-570.98%	0.41%	$ 93.46 B	1.18%
HRMY	12.01	1.92	16.00%	0.00%	$ 1.75 B	16.20%
VRTX	25.44	5.70	22.41%	0.00%	$ 110.37 B	35.51%
CAH	30.33	-17.65	-58.20%	1.02%	$ 47.16 B	0.62%
ADMA	11.76	4.98	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arena Pharmaceuticals

Arena Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2000

Time since IPO - 26 years

320

Employees

Arena Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.11 Billions, with shareholders equity totaling $673.24 Millions.

The company employs approximately 320 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Arena Pharmaceuticals Inc. reported $-3.53 Millions in revenue, generating net income of $-616.43 Millions.

Key financial metrics include a P/E ratio of -9.92, a price-to-book (P/B) ratio of 9.08, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARNA.

Market cap

$ 6.11 Billions

Net worth

$ 673.24 Millions

$ 673,237,000.00

Assets

$ 784.71 Millions

$ 784,705,000.00

Total Shares Outstanding

61.14 Millions

61,140,000

Average Daily Trading Volume

$ 1.67 Million

$ 1,666,914.84

Sector

Health Care

Industry

Biotechnology

ARNA

ARNA revenue and profits

Financial Results ARNA

DRAG THE FRAME TO SEE MORE DATA

ARNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 756.47 6,76% (12M)

P/E

19.63

0.41%

ROE

-570.98%

P/BV

-112.06

CAH - Cardinal Health

$ 199.84 32,33% (12M)

P/E

30.33

1.02%

ROE

-58.20%

P/BV

-17.65

JNJ - Johnson & Johnson

$ 231.29 56,90% (12M)

P/E

26.67

2.23%

ROE

25.92%

P/BV

6.91

MRK - Merck & Co.

$ 120.24 63,56% (12M)

P/E

33.87

2.71%

ROE

19.45%

P/BV

6.59

AZN - AstraZeneca

$ 185.65 33,28% (12M)

P/E

27.89

1.71%

ROE

21.93%

P/BV

6.11

ABBV - AbbVie

$ 215.40 21,39% (12M)

P/E

105.03

3.12%

ROE

-54.98%

P/BV

-57.74

NVO - Novo Nordisk

$ 44.55 --31,91% (12M)

P/E

10.53

4.15%

ROE

60.40%

P/BV

6.36

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 756.47 6,76% (12 M)

P/L

19.63

0.41%

ROE

-570.98%

P/VP

-112.06

CAH - Cardinal Health

$ 199.84 32,33% (12 M)

P/L

30.33

1.02%

ROE

-58.20%

P/VP

-17.65

JNJ - Johnson & Johnson

$ 231.29 56,90% (12 M)

P/L

26.67

2.23%

ROE

25.92%

P/VP

6.91

MRK - Merck & Co.

$ 120.24 63,56% (12 M)

P/L

33.87

2.71%

ROE

19.45%

P/VP

6.59

AZN - AstraZeneca

$ 185.65 33,28% (12 M)

P/L

27.89

1.71%

ROE

21.93%

P/VP

6.11

ABBV - AbbVie

$ 215.40 21,39% (12 M)

P/L

105.03

3.12%

ROE

-54.98%

P/VP

-57.74

NVO - Novo Nordisk

$ 44.55 --31,91% (12 M)

P/L

10.53

4.15%

ROE

60.40%

P/VP

6.36

Frequently Asked Questions

What is the price of Arena Pharmaceuticals (ARNA) today?

The current price of Arena Pharmaceuticals (ARNA) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Arena Pharmaceuticals (ARNA) pay dividends?

Arena Pharmaceuticals (ARNA) did not pay dividends over the past year.

Is Arena Pharmaceuticals (ARNA) a good investment?

Arena Pharmaceuticals (ARNA) is currently trading at $ 0.00 with a P/E ratio of -9.92. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Arena Pharmaceuticals (ARNA) stock?

You can buy Arena Pharmaceuticals (ARNA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ARNA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Arena Pharmaceuticals (ARNA) yield today?

Over the past month, Arena Pharmaceuticals (ARNA) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Arena Pharmaceuticals (ARNA) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARNA

Arena Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARNA

review the fundamentals of Arena Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Arena Pharmaceuticals

Arena Pharmaceuticals Inc.

United States

29 years

2000

320

PROFIT X PRICE ARNA

Financial Results ARNA

ARNA cash flow

Asset, Revenue and Profit Growth - ARNA

ARNA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions